In 2016, the World Health Organisation (WHO) defined a new type of anaplastic large cell lymphoma (BIA-ALCL) which is, itself, an uncommon type of non-Hodgkin lymphoma with several subtypes. The uncommon cancer of the white blood cells grows in response to the body’s reaction to a breast implant.
In the UK, the majority of BIA-ALCL is diagnosed early and cured by removal of the implants with surrounding scar tissue. However in a small number of cases, further treatment is required.
The UK Government has produced new helpful guidance about BIA-ALCL written by the Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG) for people with breast implants. It is in the form of questions, asked of clinicians in consultation with their patients.
Click here to visit the website for the most up to date guidance.
October 2022 is Breast Cancer Awareness Month
Around 55,000 women in the UK are diagnosed with breast cancer every year and it is the most common cancer in the UK. However, through early detection via breast screenings, having any symptoms checked by your GP, and improvements in treatments, there is a much greater chance of survival, which has doubled in the past 40 years.
For support resources and further information, read the LiveWell article on Connects.